KTB Stock Analysis: Kontoor Brands | NYSE
Apparel Manufacturing | NYSE, USA | Market Cap: 4.317m USD | 12M Return: 17.2% | US50050N1037 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 57.1M
EPS Trend: 98.1%
Qual. Beats: 1
Rev. Trend: 80.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kontoor Brands (NYSE: KTB) is a US-based lifestyle apparel company that designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories. It was incorporated in 2018, is headquartered in Greensboro, North Carolina, and was spun off from VF Corporation in May 2019. The company operates within the Consumer Discretionary sector, in the Apparel, Accessories & Luxury Goods sub-industry.
The business is organized around two core reportable segments, Wrangler and Lee, with the addition of the Helly Hansen brand extending the company into outdoor and performance apparel. Kontoor also licenses the Musto, Chic, and Rock & Republic names. Products are sold through mass merchants, outdoor and sporting goods retailers, specialty and department stores, company-operated stores, business-to-business workwear and uniform customers, and online channels including digital marketplaces, using both wholesale and direct-to-consumer routes.
The company operates globally across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Its model pairs consumer-facing denim and lifestyle brands, which are exposed to discretionary retail cycles, with B2B workwear and uniform revenue that tends to be more recurring and less sensitive to consumer sentiment.
- Helly Hansen acquisition fuels international revenue and margin growth
- Wrangler segment faces softer US denim demand and inventory pressure
- DTC channel expansion drives gross margin improvement
| Net Income: 267.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 4.86 > 1.0 |
| NWC/Revenue: 16.97% < 20% (prev 24.80%; Δ -7.83% < -1%) |
| CFO/TA 0.17 > 3% & CFO 446.1m > Net Income 267.9m |
| Net Debt (1.35b) to EBITDA (436.5m): 3.08 < 3 |
| Current Ratio: 1.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.5m) vs 12m ago -0.86% < -2% |
| Gross Margin: 49.71% > 18% (prev 45.48%; Δ 4.23% > 0.5%) |
| Asset Turnover: 114.0% > 50% (prev 97.53%; Δ 16.52% > 0%) |
| Interest Coverage Ratio: 5.53 > 6 (EBIT TTM 388.8m / Interest Expense TTM 70.3m) |
| A: 0.20 (Total Current Assets 1.15b - Total Current Liabilities 627.3m) / Total Assets 2.67b |
| B: 0.11 (Retained Earnings 280.6m / Total Assets 2.67b) |
| C: 0.14 (EBIT TTM 388.8m / Avg Total Assets 2.69b) |
| D: 0.30 (Book Value of Equity 618.5m / Total Liabilities 2.05b) |
| Altman-Z'' = 2.91 = A |
| DSRI: 0.63 (Receivables 220.8m/304.8m, Revenue 3.07b/2.65b) |
| GMI: 0.91 (GM 45.48% / 49.71%) |
| AQI: 1.09 (AQ_t 0.48 / AQ_t-1 0.44) |
| SGI: 1.16 (Revenue 3.07b / 2.65b) |
| TATA: -0.07 (NI 267.9m - CFO 446.1m) / TA 2.67b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of August 23, 2026, the stock is trading at USD 82.01 with a total of 614,014 shares traded. Over the past week, the price has changed by -3.40%, over one month by -3.86%, over three months by +19.11% and over the past year by +17.20%.
Current recommended Stop Loss: 77.90 (which is 5% or 1.2 ATR below the current price).
Kontoor Brands has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold KTB.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 97.7 | 19.1% |
P/E Trailing = 16.6295
P/E Forward = 10.6838
P/S = 1.257
P/B = 7.2604
Revenue TTM = 3.07b USD
EBIT TTM = 388.8m USD
EBITDA TTM = 436.5m USD
Long Term Debt = 1.13b USD (from longTermDebt, last fiscal year)
Short Term Debt = 47.2m USD (from shortTermDebt, last quarter)
Debt = 1.40b USD (from shortLongTermDebtTotal, last quarter) + Leases 131.6m
Net Debt = 1.35b USD (calculated: Debt 1.40b - CCE 58.5m)
Enterprise Value = 5.66b USD (4.32b + Debt 1.40b - CCE 58.5m)
Interest Coverage Ratio = 5.53 (Ebit TTM 388.8m / Interest Expense TTM 70.3m)
EV/FCF = 13.38x (Enterprise Value 5.66b / FCF TTM 423.2m)
FCF Yield = 7.47% (FCF TTM 423.2m / Enterprise Value 5.66b)
FCF Margin = 13.79% (FCF TTM 423.2m / Revenue TTM 3.07b)
Net Margin = 8.73% (Net Income TTM 267.9m / Revenue TTM 3.07b)
Gross Margin = 49.71% ((Revenue TTM 3.07b - Cost of Revenue TTM 1.54b) / Revenue TTM)
Gross Margin QoQ = 56.18% (prev 53.70%)
Tobins Q-Ratio = 2.12 (Enterprise Value 5.66b / Total Assets 2.67b)
Interest Expense / Debt = 5.00% (Interest Expense 70.3m / Debt 1.40b)
Taxrate = 23.57% (70.6m / 299.3m)
NOPAT = 297.1m (EBIT 388.8m * (1 - 23.57%))
Current Ratio = 1.83 (Total Current Assets 1.15b / Total Current Liabilities 627.3m)
Debt / Equity = 2.27 (Debt 1.40b / totalStockholderEquity, last quarter 618.5m)
Debt / EBITDA = 3.08 (Net Debt 1.35b / EBITDA 436.5m)
Debt / FCF = 3.18 (Net Debt 1.35b / FCF TTM 423.2m)
Total Stockholder Equity = 583.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.95% (Net Income 267.9m / Total Assets 2.67b)
RoE = 45.96% (Net Income TTM 267.9m / Total Stockholder Equity 583.0m)
RoCE = 22.63% (EBIT 388.8m / Capital Employed (Equity 583.0m + L.T.Debt 1.13b))
RoIC = 14.66% (NOPAT 297.1m / Invested Capital 2.03b)
WACC = 8.36% (E(4.32b)/V(5.72b) * Re(9.83%) + D(1.40b)/V(5.72b) * Rd(5.00%) * (1-Tc(0.24)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -72.35 | Cagr: -0.98%
[DCF] Terminal Value 77.95% ; FCFF base≈373.7m ; Y1≈428.3m ; Y5≈630.4m
[DCF] Fair Price = 148.8 (EV 9.48b - Net Debt 1.35b = Equity 8.13b / Shares 54.7m; r=8.36% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.07 | EPS CAGR: 12.10% | SUE: 3.58 | # QB: 1
Revenue Correlation: 80.23 | Revenue CAGR: 7.59% | SUE: -0.04 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.34 | Chg30d=-0.77% | Revisions=+0% | Analysts=9
EPS current Year (2026-12-31): EPS=5.29 | Chg30d=+1.68% | Revisions=+17% | GrowthEPS=-5.4% | GrowthRev=-14.3%
EPS next Year (2027-12-31): EPS=6.58 | Chg30d=+3.26% | Revisions=-17% | GrowthEPS=+24.5% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +0% (up=4, down=4)